EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Predictors of Cryptococcus gattii Clinical Presentation and Outcome: An International Study

Eleni Galanis iD, Laura MacDougall, Caren Rose, Sharon C A Chen, Hanna N Oltean, Paul R Cieslak iD, Emilio DeBess, Mei Chong, Tania C Sorrell, John W Baddley iD, Linda M N Hoang, Shawn R Lockhart und 2 weitere

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciae640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Eleni Galanis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Cryptococcus gattii, Cryptococcosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck, Astellas Pharma, Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infection by Cryptococcus gattii can lead to pulmonary or central nervous system (CNS) disease, or both. Whether the sites of infection and disease severity are associated with C. gattii species and lineages or with certain underlying medical conditions, or both is unclear. We conducted a retrospective cohort study to identify factors associated with site of infection and mortality among C. gattii cases.

Methods

We extracted data on 258 C. gattii cases from Australia, Canada, and the United States reported from 1999 to 2011. We conducted unadjusted and multivariable logistic regression analyses to evaluate factors associated with site of infection and C. gattii mortality among hospitalized cases (N = 218).

Results

Hospitalized C. gattii cases with CNS and other extrapulmonary disease were younger, more likely to reside in Australia, and be infected with variety gattii I (VGI) lineage but less likely to have comorbidities and die as compared to cases with pulmonary disease. The odds of having CNS and/or other extrapulmonary disease were 9 times higher in cases with VGI infection (adjusted odds ratio [aOR] = 9.21, 95% confidence interval [CI] = 3.28–25.89). Age ≥70 years (aOR = 6.69, 95% CI = 2.44–18.30), chronic lung disease (aOR = 2.62, 95% CI = 1.05–6.51) and an immunocompromised status (aOR = 2.08, 95% CI = 1.05–6.51) were associated with higher odds of C. gattii mortality.

Conclusions

Among hospitalized cases, C. gattii species and lineage are associated with site of infection but not with the risk of death, whereas older age and comorbidities increase the risk of death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryptococcus gattiiCryptococcosisHumansMaleFemaleAgedRetrospective StudiesMiddle AgedCanadaAustraliaAdultUnited StatesAged, 80 and overYoung AdultRisk FactorsAdolescentChildChild, PreschoolInfant

Stichwörter der Autor:innen

Cryptococcus gattiiinfectionmortalitypredictive factors

Autor:innen und Institutionen

  • Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.
  • Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Washington Department of Health, Seattle, Washington, USA.
  • Oregon Department of Health, Portland, Oregon, USA.

ORCID-Profile: Eleni Galanis, Paul R Cieslak, John W Baddley, Peter G Pappas, Peter Phillips

Förderung

  • Merck
  • Astellas Pharma
  • Pfizer

Zitieren

APA

Galanis, E., MacDougall, L., Rose, C., Chen, S. C. A., Oltean, H. N., Cieslak, P. R., DeBess, E., Chong, M., Sorrell, T. C., Baddley, J. W., Hoang, L. M. N., Lockhart, S. R., Pappas, P. G., & Phillips, P. (2025). Predictors of Cryptococcus gattii Clinical Presentation and Outcome: An International Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae640

Vancouver

Galanis E, MacDougall L, Rose C, Chen SCA, Oltean HN, Cieslak PR, et al. Predictors of Cryptococcus gattii Clinical Presentation and Outcome: An International Study. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciae640

BibTeX
@article{Galanis2025,
  author = {Galanis, Eleni and MacDougall, Laura and Rose, Caren and Chen, Sharon C A and Oltean, Hanna N and Cieslak, Paul R and DeBess, Emilio and Chong, Mei and Sorrell, Tania C and Baddley, John W and Hoang, Linda M N and Lockhart, Shawn R and Pappas, Peter G and Phillips, Peter},
  title = {Predictors of Cryptococcus gattii Clinical Presentation and Outcome: An International Study},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciae640}
}
Kostenlos starten →